<i>In Vitro</i> Skin Retention of Crisaborole after Topical Application

• Main Authors: Adriana Fantini (Author), Anna Demurtas (Author), Sara Nicoli (Author), Cristina Padula (Author), Silvia Pescina (Author), Patrizia Santi (Author)
• Format: Book
• Published: MDPI AG, 2020-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Crisaborole, a nonsteroidal phosphodiesterase 4 inhibitor, represents the first nonsteroidal medication approved for the treatment of atopic dermatitis in over a decade. In this work, crisaborole skin permeation and retention was studied <i>in vitro</i> from a 2% ointment using porcine s...